Enhancement of red blood cell transfusion compatibility using CRISPR‐mediated erythroblast gene editing

Abstract excerpt

Abstract Regular blood transfusion is the cornerstone of care for patients with red blood cell (RBC) disorders such as thalassaemia or sickle‐cell disease. With repeated transfusion, alloimmunisation often occurs due to incompatibility at the level of minor blood group antigens. We use CRISPR‐mediated genome editing of an immortalised human erythroblast cell line (BEL‐A) to generate multiple enucleation competent...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Blood groups and transfusion
• Share to CRISPR and Genetic Engineering
• Share to Erythrocyte Function and Pathophysiology